Xspray Pharma AB (publ)

OM:XSPRAY Stock Report

Market Cap: kr1.3b

Xspray Pharma Management

Management criteria checks 1/4

Xspray Pharma's CEO is Per Andersson, appointed in Jan 2006, has a tenure of 18.33 years. total yearly compensation is SEK3.74M, comprised of 70.5% salary and 29.5% bonuses, including company stock and options. directly owns 0.66% of the company’s shares, worth SEK8.34M. The average tenure of the management team and the board of directors is 0.5 years and 5 years respectively.

Key information

Per Andersson

Chief executive officer

kr3.7m

Total compensation

CEO salary percentage70.5%
CEO tenure18.3yrs
CEO ownership0.7%
Management average tenureless than a year
Board average tenure5yrs

Recent management updates

Recent updates

We Think Xspray Pharma (STO:XSPRAY) Needs To Drive Business Growth Carefully

Feb 25
We Think Xspray Pharma (STO:XSPRAY) Needs To Drive Business Growth Carefully

We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate

May 11
We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate

We Think Xspray Pharma (STO:XSPRAY) Can Afford To Drive Business Growth

Feb 01
We Think Xspray Pharma (STO:XSPRAY) Can Afford To Drive Business Growth

We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate

Oct 26
We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate

We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate

Jun 20
We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate

We're Hopeful That Xspray Pharma (STO:XSPRAY) Will Use Its Cash Wisely

Mar 19
We're Hopeful That Xspray Pharma (STO:XSPRAY) Will Use Its Cash Wisely

Do Institutions Own Xspray Pharma AB (publ) (STO:XSPRAY) Shares?

Feb 12
Do Institutions Own Xspray Pharma AB (publ) (STO:XSPRAY) Shares?

Here's Why We're Watching Xspray Pharma's (STO:XSPRAY) Cash Burn Situation

Dec 04
Here's Why We're Watching Xspray Pharma's (STO:XSPRAY) Cash Burn Situation

CEO Compensation Analysis

How has Per Andersson's remuneration changed compared to Xspray Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023kr4mkr3m

-kr180m

Sep 30 2023n/an/a

-kr180m

Jun 30 2023n/an/a

-kr170m

Mar 31 2023n/an/a

-kr148m

Dec 31 2022kr4mkr2m

-kr132m

Sep 30 2022n/an/a

-kr128m

Jun 30 2022n/an/a

-kr114m

Mar 31 2022n/an/a

-kr102m

Dec 31 2021kr3mkr2m

-kr97m

Sep 30 2021n/an/a

-kr60m

Jun 30 2021n/an/a

-kr57m

Mar 31 2021n/an/a

-kr56m

Dec 31 2020kr3mkr2m

-kr52m

Sep 30 2020n/an/a

-kr56m

Jun 30 2020n/an/a

-kr55m

Mar 31 2020n/an/a

-kr49m

Dec 31 2019kr3mkr2m

-kr46m

Sep 30 2019n/an/a

-kr41m

Jun 30 2019n/an/a

-kr34m

Mar 31 2019n/an/a

-kr30m

Dec 31 2018kr2mkr2m

-kr23m

Sep 30 2018n/an/a

-kr17m

Jun 30 2018n/an/a

-kr16m

Mar 31 2018n/an/a

-kr8m

Dec 31 2017kr2mkr1m

-kr14m

Compensation vs Market: Per's total compensation ($USD340.31K) is above average for companies of similar size in the Swedish market ($USD240.79K).

Compensation vs Earnings: Per's compensation has increased whilst the company is unprofitable.

CEO

Per Andersson (56 yo)

18.3yrs

Tenure

kr3,743,000

Compensation

Dr. Per Andersson Ph.D. has been the Chief Executive Officer of Xspray Pharma AB (publ) since 2006. Dr. Andersson serves as the Chief Executive Officer of Xspray Microparticles AB. Dr. Andersson joined XSp...

Leadership Team

NamePositionTenureCompensationOwnership
Per Andersson
Chief Executive Officer18.3yrskr3.74m0.66%
SEK 8.3m
Mustafa Demirbüker
Co-Founder and Science Directorno datano datano data
Michael Winklerfelt
Acting Chief Financial Officerless than a yearno datano data
Gérald Jesson
Vice President of Operationsno datano datano data
Kerstin Hasselgren
Senior Advisor & Head of IRless than a yearno data0.026%
SEK 334.0k
Linda Glimberg
Senior Vice President of Legalless than a yearno data0.0058%
SEK 72.9k
Charlotta Liljebris
Senior Vice President of Research & Development6.3yrsno data0.0096%
SEK 121.5k
Edward Jordan
Chief Commercial Officerless than a yearno datano data
Anette Abrahamsson
Senior Vice President of Regulatory Affairsless than a yearno data0.0048%
SEK 60.8k
Christer Hallgren
Senior Vice President of Intellectual Property6.3yrsno data0.096%
SEK 1.2m

0.5yrs

Average Tenure

55.5yo

Average Age

Experienced Management: XSPRAY's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Maris Hartmanis
Independent Director9.3yrskr323.00k0%
SEK 0
Carl-Johan Spak
Independent Director9.3yrskr270.00kno data
Anders Ekblom
Chairman3yrskr510.00k0%
SEK 0
Torbjörn Koivisto
Independent Director7.3yrskr253.00k0%
SEK 0
Christine Lind
Independent Director5yrskr270.00k0%
SEK 0
Anders Bladh
Director3yrskr253.00k2.24%
SEK 28.4m
Robert Molander
Independent Director2yrskr218.00k0.032%
SEK 405.0k

5.0yrs

Average Tenure

65yo

Average Age

Experienced Board: XSPRAY's board of directors are considered experienced (5 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.